New patent for the drug Braintree Labs SUTAB – DrugPatentWatch
Annual Drug Patent Expiration for SUTAB
Sutab is a drug marketed by Braintree Labs and is included in one NDA. It is available from a single supplier. There are three patents protecting this drug.
SUTAB drug price trends.
The generic ingredient in SUTAB is magnesium sulfate; potassium chloride; sodium sulfate. One registered supplier for this compound. Additional details are available on the magnesium sulfate; potassium chloride; sodium sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the Braintree Labs drug SUTAB
